Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers
Open Access
- 14 June 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 327 (22) , 2201-2209
Abstract
Black adults in the US have higher rates of smoking-related morbidity and mortality compared with White adults, despite having comparable smoking prevalence and smoking fewer cigarettes per day.1-4 Although they report greater interest in quitting, Black smokers are less likely than White smokers to be advised to quit or achieve sustained smoking abstinence and have been underrepresented in tobacco treatment research.1,5 Advancing treatment for Black smokers must include light smokers, because more than 65% of Black individuals who smoke use 10 or fewer cigarettes per day.2,6 Light smokers report nicotine dependence and experience substantial tobacco-related disease,7-10 but have been largely excluded from smoking cessation clinical trials.11,12 Clinical practice guidelines articulate the need for research addressing treatment for light smokers and for Black smokers.12,13Keywords
This publication has 37 references indexed in Scilit:
- Bupropion for Smoking Cessation in African American Light Smokers: A Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2012
- A Pilot Clinical Trial of Varenicline for Smoking Cessation in Black SmokersNicotine & Tobacco Research, 2011
- Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological dataTrials, 2011
- A Quantitative Estimate of the Clinical Significance of Treating Tobacco DependenceAmerican Journal of Preventive Medicine, 2010
- Health Effects of Light and Intermittent SmokingCirculation, 2010
- Light and intermittent smokers: Background and perspectiveNicotine & Tobacco Research, 2009
- Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale.Psychology of Addictive Behaviors, 2007
- The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial designAddiction, 2006
- Measures of abstinence in clinical trials: issues and recommendationsNicotine & Tobacco Research, 2003
- Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smokingBritish Journal of Clinical Pharmacology, 1997